Transcriptional Programming of Dendritic Cells for Enhanced MHC Class II Antigen Presentation

Bryan Vander Lugt,Aly A Khan,Jason A Hackney,Smita Agrawal,Justin Lesch,Meijuan Zhou,Wyne P Lee,Summer Park,Min Xu,Jason DeVoss,Chauncey J Spooner,Cecile Chalouni,Lelia Delamarre,Ira Mellman,Harinder Singh
DOI: https://doi.org/10.1038/ni.2795
IF: 30.5
2013-01-01
Nature Immunology
Abstract:CD11b(+) dendritic cells (DCs) seem to be specialized for presenting antigens via major histocompatibility (MHC) class II complexes to stimulate helper T cells, but the genetic and regulatory basis for this is not established. Conditional deletion of Irf4 resulted in loss of CD11b(+) DCs, impaired formation of peptide-MHC class II complexes and defective priming of helper T cells but not of cytotoxic T lymphocyte (CTL) responses. Gene expression and chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) analyses delineated an IRF4-dependent regulatory module that programs enhanced MHC class II antigen presentation. Expression of the transcription factor IRF4 but not of IRF8 restored the ability of IRF4-deficient DCs to efficiently process and present antigen to MHC class II-restricted T cells and promote helper T cell responses. We propose that the evolutionary divergence of IRF4 and IRF8 facilitated the specialization of DC subsets for distinct modes of antigen presentation and priming of helper T cell versus CTL responses.
What problem does this paper attempt to address?